Page 7 - Haematologica Vol. 110 - January 2025

Plasma Cell DIsorders
153 Unlocking the therapeutic potential of selective CDK7 and BRD4 inhibition against multiple myeloma cell growth
Y. Yao et al. https://doi.org/10.3324/haematol.2024.285491
Plasma Cell Disorders
163 Risk of infections in multiple myeloma. A population-based study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry
C.H. Blimark et al.
https://doi.org/10.3324/haematol.2024.285645
Letters to the Editor
173 Rituximab maintenance after bendamustine-based treatment for follicular lymphoma and mantle cell lymphoma may exert a negative influence on SARS-CoV-2 infection outcomes
A. Serna et al.
https://doi.org/10.3324/haematol.2024.285219
179 Respiratory syncytial virus and other vaccine-preventable infections in multiple myeloma. A population- based study on 8,672 myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry
S. Einarsdottir et al.
https://doi.org/10.3324/haematol.2024.285161
183 Safety and efficacy of human apotransferrin infusion in patients with β-thalassemia intermedia: the AIM study
K. Konté et al. https://doi.org/10.3324/haematol.2024.285045
187 Increased frequency of clonal hematopoiesis of indeterminate potential in Bloom syndrome probands and carriers
I. Lin et al. https://doi.org/10.3324/haematol.2024.285239
193 Hodgkin/Reed-Sternberg cells induce GPNMB expression and release from macrophages to suppress T-cell responses to the Epstein-Barr virus-encoded LMP2A protein
N. Masand et al.
https://doi.org/10.3324/haematol.2024.285319
200 A novel prognostic nomogram based on imaging and molecular parameters for newly diagnosed extranodal natural killer/T-cell lymphoma patients
D. Huang et al.
https://doi.org/10.3324/haematol.2024.285362
206 Contribution of copy number to improve risk stratification of adult T-cell acute lymphoblastic leukemia patients enrolled in measurable residual disease-oriented trials
C. González-Gil et al.
https://doi.org/10.3324/haematol.2024.285416
212 Cd39 and P2rx7-Wnt signaling enhance blast pathogenicity in an experimental model of acute myeloid leukemia
L. Feng et al. https://doi.org/10.3324/haematol.2024.285547
218 Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy
S. Mercadal et al. https://doi.org/10.3324/haematol.2024.285613
Haematologica | 110 January 2025
III